Shares of Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.51 and traded as low as $1.20. Aytu BioPharma shares last traded at $1.20, with a volume of 21,489 shares trading hands.
Aytu BioPharma Stock Down 1.2 %
The business has a fifty day moving average price of $1.51 and a two-hundred day moving average price of $1.82. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.98 and a quick ratio of 0.81. The firm has a market cap of $7.43 million, a PE ratio of -0.83 and a beta of -1.63.
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The company reported ($0.28) EPS for the quarter. Aytu BioPharma had a negative net margin of 7.62% and a negative return on equity of 19.30%.
Hedge Funds Weigh In On Aytu BioPharma
Aytu BioPharma Company Profile
Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.
See Also
- Five stocks we like better than Aytu BioPharma
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- How to Build the Ultimate Everything ETF Portfolio
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Short Nasdaq: An Easy-to-Follow Guide
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.